The Latin America, Middle East and Africa Disposable Syringes Market should witness market growth of 8.8% CAGR during the forecast period (2023-2030).
The need to stop the spread of diseases like HIV and the increasing demand for disposable syringes are the key drivers driving this market. Other important aspects include increasing awareness-raising efforts by various NGOs. To prevent contamination, disposable syringes must be used properly. These containers have leak-proof sides and a bottom made of polyethylene that won't puncture easily. This rising awareness regarding the safe syringe practices is predicted to support the growth of market. In modern medicine, these syringes are frequently used to inject medications, draw blood samples, and administer vaccinations.
Controlling the spread of infectious diseases like HIV is another element positively impacting target market. The unsafe syringe disposal practice is one of the factors contributing to the high incidence of HIV. In 2021, the World Health Organization (WHO) estimated that there were 38.4 million [33.9-43.8 million] persons living with HIV at the end of the year, of which two-thirds (25.6 million) were in the WHO African Region. These increasing cases of HIV cases across the region are further predicted to support the growth of the market.
According to statistics provided by the UAE’s government under Chronic Illness and Natural Disorders in March 2023, the UAE reports 4,500 new cancer cases yearly. In 2021, 73 million adults (20-79) in the IDF MENA Region had diabetes, according to the most recent data from the International Diabetes Federation. By 2030 and 2045, this number is projected to rise to 95 million and 136 million, respectively. In 2021, USD 33 billion was spent on diabetes-related medical expenses. they wish to build their healthcare sector as a hub for medical tourism. It is anticipated that these factors will increase regional demand.
The Brazil market dominated the LAMEA Disposable Syringes Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $479.9 Million by 2030. The Argentina market is anticipated to grow at a CAGR of 9.3% during (2023-2030). Additionally, The UAE market would showcase a CAGR of 8.4% during (2023-2030).
Based on Application, the market is segmented into Therapeutic Injections, and Immunization Injections. Based on Product, the market is segmented into Safety Syringes (Retractable, and Non-retractable), and Conventional Syringes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Fresenius SE & Co. KGaA, Terumo Corporation, Novo Nordisk A/S, Baxter International, Inc., B. Braun Melsungen AG, Flextronics International, Ltd., Nipro Corporation, and UltiMed, Inc.
The need to stop the spread of diseases like HIV and the increasing demand for disposable syringes are the key drivers driving this market. Other important aspects include increasing awareness-raising efforts by various NGOs. To prevent contamination, disposable syringes must be used properly. These containers have leak-proof sides and a bottom made of polyethylene that won't puncture easily. This rising awareness regarding the safe syringe practices is predicted to support the growth of market. In modern medicine, these syringes are frequently used to inject medications, draw blood samples, and administer vaccinations.
Controlling the spread of infectious diseases like HIV is another element positively impacting target market. The unsafe syringe disposal practice is one of the factors contributing to the high incidence of HIV. In 2021, the World Health Organization (WHO) estimated that there were 38.4 million [33.9-43.8 million] persons living with HIV at the end of the year, of which two-thirds (25.6 million) were in the WHO African Region. These increasing cases of HIV cases across the region are further predicted to support the growth of the market.
According to statistics provided by the UAE’s government under Chronic Illness and Natural Disorders in March 2023, the UAE reports 4,500 new cancer cases yearly. In 2021, 73 million adults (20-79) in the IDF MENA Region had diabetes, according to the most recent data from the International Diabetes Federation. By 2030 and 2045, this number is projected to rise to 95 million and 136 million, respectively. In 2021, USD 33 billion was spent on diabetes-related medical expenses. they wish to build their healthcare sector as a hub for medical tourism. It is anticipated that these factors will increase regional demand.
The Brazil market dominated the LAMEA Disposable Syringes Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $479.9 Million by 2030. The Argentina market is anticipated to grow at a CAGR of 9.3% during (2023-2030). Additionally, The UAE market would showcase a CAGR of 8.4% during (2023-2030).
Based on Application, the market is segmented into Therapeutic Injections, and Immunization Injections. Based on Product, the market is segmented into Safety Syringes (Retractable, and Non-retractable), and Conventional Syringes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Fresenius SE & Co. KGaA, Terumo Corporation, Novo Nordisk A/S, Baxter International, Inc., B. Braun Melsungen AG, Flextronics International, Ltd., Nipro Corporation, and UltiMed, Inc.
Scope of the Study
By Application
- Therapeutic Injections
- Immunization Injections
By Product
- Safety Syringes
- Retractable
- Non-retractable
- Conventional Syringes
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Medtronic PLC
- Fresenius SE & Co. KGaA
- Terumo Corporation
- Novo Nordisk A/S
- Baxter International, Inc.
- B.Braun Melsungen AG
- Flextronics International, Ltd.
- Nipro Corporation
- UltiMed, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Disposable Syringes Market by Application
Chapter 4. LAMEA Disposable Syringes Market by Product
Chapter 5. LAMEA Disposable Syringes Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Becton, Dickinson and Company
- Medtronic PLC
- Fresenius SE & Co. KGaA
- Terumo Corporation
- Novo Nordisk A/S
- Baxter International, Inc.
- B. Braun Melsungen AG
- Flextronics International, Ltd.
- Nipro Corporation
- UltiMed, Inc.
Methodology
LOADING...
